Bfsg, LLC Uni Qure N.V. Transaction History

Bfsg, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 26, 2021	SELL	$29.24 - $42.03 $472,109 - $678,616	-16,146 Closed	0 $0
Q4 2020 Jan 26, 2021	BUY	$35.35 - $50.67 $570,761 - $818,117	16,146 New	16,146 $583,000
Q1 2020 Apr 27, 2020	SELL	$40.01 - $73.97 $284,991 - $526,888	-7,123 Closed	0 $0
Q4 2019 Jan 29, 2020	BUY	$37.13 - $74.62 $264,476 - $531,518	7,123 New	7,123 $510,000

142

35.3M

1.54M

389K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $300M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of Bfsg, LLC, based on Form 13F filings with the SEC.

Stay updated on Bfsg, LLC with notifications on news.